Archives

by in
Entry Author Date Location
Who Will Keep the Flame Alive for Seattle Biotech? Hear From the Players Nov. 29 11/09/10 Seattle
Q&A With Doug Williams: Reflecting on ZymoGenetics, Looking Ahead at Seattle Biotech 11/09/10 Seattle
Biotech’s Back in Seattle: Xconomy Forum to Convene Leaders of Dendreon, Seattle Genetics 10/13/10 Seattle
Seattle Genetics, Millennium Nail 2nd Straight Trial With “Empowered Antibody” For Cancer 10/11/10 Seattle
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer 09/27/10 Seattle
Seattle Genetics’ Dark Horse Drug Candidate Fails in Key Study 09/13/10 Seattle
Seattle Genetics’ Dark Horse Drug Candidate Approaches Home Stretch in Leukemia Study 06/22/10 Seattle
Genentech’s Souped-Up Herceptin: The Odyssey Toward a More Powerful Breast Cancer Drug 06/14/10 San Francisco
Seattle Genetics, Growing Up in a Hurry With Millennium, Aims to Make Most of Cancer Drug 05/26/10 Seattle
The Value of Bumping Into People in the Hall: A Lesson from the JP Morgan Healthcare Conference 01/15/10 Seattle
Alder Rises from Ashes, Seattle Genetics Gets Empowered, ZymoGenetics Nets $79M & More Seattle-Area Life Sciences News 01/07/10 Seattle
Seattle Genetics Maps Out a Future With Antibody Drugs That Are “Empowered” 01/06/10 Seattle
The 12 Days of Xconomists: Leading Innovators Give Their Top Advances of the Past Decade 01/05/10 National
Alder Rises From Ashes of Layoffs to Become Seattle Biotech Force 01/04/10 Seattle
Dendreon Nails Down $409M, Stewart Parker Gets Itch to Return, Seattle Genetics Finds New Partner, & More Seattle-Area Life Sciences News 12/17/09 Seattle
The Top Five Biotech Innovations of the 2000s 12/15/09 Seattle
Seattle Genetics Nabs $60M Upfront From Millennium For “Empowered Antibody” 12/15/09 Seattle
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News 11/12/09 Seattle
Alder and New Partner, Bristol, to Give Amgen and Abbott a Run for Their Money 11/11/09 Seattle
Seattle Genetics Shares Drop on Halted Lymphoma Trial 10/05/09 Seattle
Seattle Genetics “Empowered Antibody” Wipes Out Hodgkin’s Tumors in Early Study 06/01/09 Seattle
Seattle Genetics’ Financing Tale, Johnny Stine Sticks it to VCs, Puget Sound’s Biotech Universe, & More Seattle-Area Life Sciences News 02/12/09 Seattle
Hey, Don’t Forget the Puget Sound Life Sciences Universe! 02/09/09 Seattle
Seattle Genetics Defies Gravity With Biotech’s First Underwritten Stock Sale in Six Months 02/05/09 Seattle
Dendreon Expects Results in April, Seattle Genetics Plans Hodgkin’s Trial, ImaRx Moves to Town & More Seattle-Area Life Sciences News 01/22/09 Seattle
Seattle Genetics Unveils Pivotal Trial Plan for “Empowered Antibody” 01/21/09 Seattle
Five Questions for Seattle Biotech, Medical Device Leaders About the Year Ahead 01/21/09 Seattle
Blood News: A Quick Rundown of Headlines From the American Society of Hematology 12/09/08 National
Seattle Genetics “Empowered Antibody” Shines at Blood Disease Meeting 12/06/08 Seattle
ZymoGenetics “Sleeper” Wakes Up, Leroy Hood Unveils New Company, CMC Icos Expands, & More Seattle-Area Life Sciences News 10/02/08 Seattle
Page 2 of 3 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. When iMovie Isn’t Enough, Amateur Video Producers Can Go Pro

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.